Nvidia joins forces with the Broad Institute

By LabPulse.com staff writers

September 21, 2022 -- Nvidia has formed a partnership with the Broad Institute of MIT and Harvard aimed at improving genome analysis workflow.

As part of the collaboration, Nvidia's Clara Parabricks graphics processing unit (GPU)-enabled software suite will be available within the institute's Terra Cloud research platform to provide secondary analysis of sequencing data. Users will then be able to analyze a whole genome in just over an hour, compared with 24 hours in a CPU-based environment, and the compute cost can be reduced by more than half, Nvidia said.

In addition, Nvidia and the Broad Institute will also codevelop large language models for the discovery and development of targeted therapies, according to the company. Using Nvidia's new BioNeMo artificial intelligence (AI) application framework, researchers will develop foundational large language models for DNA and RNA in an effort to better understand human biology.

To help researchers discover new therapies, Nvidia is also contributing a new deep-learning model directly to the Broad Institute's Genome Analysis Toolkit.

"There's a need across the healthcare ecosystem for better computational tools to enable breakthroughs in the way we understand disease, develop diagnostics and deliver treatments," said Nvidia's Vice President of Healthcare Kimberly Powell in a statement. "By expanding our collaboration with the Broad Institute, we can bring the power of large language models to ultimately deliver joint solutions and narrow the divide between insights from researchers and real benefits for patients."

Researchers at Broad Institute will also gain access to the company's Monai open-source deep-learning framework for medical imaging AI, as well as Rapids, a GPU-accelerated data science toolkit for faster data preparation in genomic single-cell analysis.

New CRISPR-based COVID-19 test shows high sensitivity
A new CRISPR-based test can produce results in 30 minutes to an hour, with similar accuracy as the standard polymerase chain reaction diagnostics now...
NIH to spend $129M to scale up COVID-19 testing
The U.S. National Institutes of Health (NIH) plans to spend about $129 million to scale up COVID-19 testing capacity and provide manufacturing support....
Key CRISPR patent revoked in Europe
An important patent on CRISPR technology held by the Broad Institute has been revoked by the European Patent Office.
NIH funds human genome reference update
The U.S. National Institutes of Health (NIH) announced on September 24 that it will grant $29.5 million to support researchers to generate and maintain...
Color gets $4.6M NIH grant for population-wide genetic counseling
California genomics company Color has been awarded a $4.6 million grant from the U.S. National Institutes of Health (NIH) to set up a nationwide...

Copyright © 2022 LabPulse.com

Last Updated lo 9/21/2022 7:59:13 AM